Skip to main content

Table 2 The clinical features and genes expressed in the CIN and normal groups

From: Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia

 

normal

CIN

Z/X2

P

age

44.08 ± 10.00

41.71 ± 9.31

−1.480

0.139

gravidity

3.00 ± 1.76

3.46 ± 1.84

−1.536

0.124

parity

1.66 ± 0.85

1.67 ± 1.34

−0.561

0.561

HPV infection

  

26.552

0.000

 positive

15

47

  

 negative

23

5

  

menopause

 yes

9

9

0.558

0.455

 no

29

43

  

TCT

 CINII-(Normal/ASCUS)

28

10

/

0.000

 CINII+(LSIL/HSIL/SCC)

16

36

  

 CTNNB1

0.85 ± 0.15

0.88 ± 0.24

−1.626

0.104

TGFBR2

1613.35 ± 369.73

665.56 ± 357.49

−2.916

0.004

FOXO1

0.04 ± 0.01

0.50 ± 0.30

−2.728

0.006

PRKCI

0.65 ± 0.22

0.56 ± 0.11

−1.675

0.094

CSKN1A1

211.45 ± 120.00

135.69 ± 81.39

−0.270

0.787

TP73

150.80 ± 44.11

75.39 ± 21.31

−1.805

0.071

MUC2

0.92 ± 0.25

1.89 ± 1.26

−0.343

0.732

PIK3CA

4.91 ± 0.87

7.28 ± 1.98

−1.005

0.315

CCND2

0.47 ± 0.19

1.40 ± 0.72

−0.556

0.579

CTPB2

40.18 ± 11.28

16.59 ± 6.14

−2.091

0.037